NKTR- Nektar Therapeutics

Name: Nektar Therapeutics Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Robin Howard W	75.9K	$4.69M	-
Other	Wilson Mark Andrew	21.6K	$1.33M	-
Other	Zalevsky Jonathan	15.4K	$953.2K	-5,538
Dir	Ajer Jeffrey Robert	8.0K	$494.0K	-
Dir	Greer R Scott	8.0K	$494.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 32

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Mar 9, 2016	Thomsen Jillian B.86	SVP &Chief Accounting Officer	Sale+OE	15,000	$11.79	$176,850.00	-74.4%
Feb 17, 2016	Gergel Ivan P.	SVP &Chief Medical Officer	Sale+OE	556	$11.92	$6,627.52	-44.5%
Feb 17, 2016	Nicholson John	SVP &Chief Financial Officer	Sale+OE	963	$11.92	$11,478.96	-1.2%
Feb 17, 2016	Robin Howard W58	President &CEO	Sale+OE	2,147	$11.92	$25,592.24	-13.7%
Feb 17, 2016	Doberstein Stephen K	SVP &Chief Scientific Officer	Sale+OE	390	$11.92	$4,648.80	-44.6%
Feb 17, 2016	Thomsen Jillian B.86	SVP &Chief Accounting Officer	Sale+OE	716	$11.92	$8,534.72	-12.2%
Feb 17, 2016	Labrucherie Gil M84	SVP &General Counsel	Sale+OE	827	$11.92	$9,857.84	-11.2%
Feb 17, 2016	Hora Maninder	SVP Pharma Dev &Mfg Ops	Sale+OE	963	$11.92	$11,478.96	-14.2%
Feb 10, 2016	Robin Howard W58	President &CEO	Sale+OE	66,666	$11.49	$765,992.34	-87.0%
Feb 10, 2016	Labrucherie Gil M84	SVP &General Counsel	Sale+OE	11,666	$11.49	$134,042.34	-69.0%

← PrevPage 32Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC